News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) IPO, Cost Cuts Give Drugmaker Time to Reinvent Its R&D Engine


8/1/2012 6:33:58 AM

Pfizer Inc. (PFE), the world’s largest drugmaker, put in place the last piece of its plan to refocus the company on developing new drugs, announcing it would start the separation of its animal-health business this month. As the drugmaker spins off the unit and makes deep spending cuts, Chief Executive Officer Ian Read has set the stage for Pfizer’s future without Lipitor, the drug that dominated the company’s sales until this year after losing market exclusivity. Top on the agenda is making New York-based Pfizer better at turning out innovative new medicines, he said.

Read at Market Watch
Read at BusinessWeek
Read at Reuters
Read at New York Times
Read at The Day


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES